| Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis N Pencheva, H Tran, C Buss, D Huh, M Drobnjak, K Busam, SF Tavazoie Cell 151 (5), 1068-1082, 2012 | 406 | 2012 |
| Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation N Pencheva, CG Buss, J Posada, T Merghoub, SF Tavazoie Cell 156 (5), 986-1001, 2014 | 179 | 2014 |
| Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins H Goodarzi, S Zhang, CG Buss, L Fish, S Tavazoie, SF Tavazoie Nature 513 (7517), 256-260, 2014 | 88 | 2014 |
| Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics CG Buss, SN Bhatia Proceedings of the National Academy of Sciences 117 (24), 13428-13436, 2020 | 57 | 2020 |
| Sustained‐Release Synthetic Biomarkers for Monitoring Thrombosis and Inflammation Using Point‐of‐Care Compatible Readouts JS Dudani, CG Buss, RTK Akana, GA Kwong, SN Bhatia Advanced functional materials 26 (17), 2919-2928, 2016 | 57 | 2016 |
| Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer SR Viswanathan, MF Nogueira, CG Buss, JM Krill-Burger, MJ Wawer, ... Nature genetics 50 (7), 937-943, 2018 | 53 | 2018 |
| Protease activity sensors noninvasively classify bacterial infections and antibiotic responses CG Buss, JS Dudani, RTK Akana, HE Fleming, SN Bhatia EBioMedicine 38, 248-256, 2018 | 28 | 2018 |
| Lung protease nanosensors and uses thereof SN Bhatia, J Kirkpatrick, JS Dudani, C Buss, AD Warren US Patent App. 16/582,053, 2020 | 11 | 2020 |
| Nanomaterial-mediated immune interactions for disease diagnosis and cancer immunotherapy CG Buss Massachusetts Institute of Technology, 2020 | | 2020 |
Hani GoodarziAssociate Professor at UCSFVerified email at ucsf.edu
